Lau Sean K, Weiss Lawrence M, Zhang Yibin, Huang Qin
Department of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Leuk Lymphoma. 2006 Mar;47(3):541-7. doi: 10.1080/10520290500305310.
Histologic transformation of follicular lymphoma is usually to a diffuse large B-cell lymphoma. We present a rare example of a histologic transformation of follicular lymphoma manifested by prolymphocytoid morphology and an unusual immunophenotype characterized by coexpression of CD5 and CD10. The transformed prolymphocytoid lymphoma was positive for CD5 and CD10 antigens by both flow cytometry and immunohistochemistry. The case also expressed bcl-2 and bcl-6 proteins, and exhibited t(14;18), consistent with derivation from a pre-existing follicular lymphoma. Polymerase chain reaction analysis of the immunoglobulin kappa light chain genes derived from the follicular lymphoma and prolymphocytoid lymphoma showed identical rearranged bands, suggesting clonal identity of the two neoplasms. The basis for coexpression of CD5 and CD10 remains unclear. Because the preceding low-grade follicular lymphoma was positive only for CD10 and did not express CD5, CD5 expression appears to be an acquired phenomenon accompanying the process of histologic transformation in this particular case. Prolymphocytoid transformation, similar to other histologic forms of transformation of follicular lymphoma, appears to accompany clinical progression of disease.
滤泡性淋巴瘤的组织学转化通常为弥漫性大B细胞淋巴瘤。我们报告了1例罕见的滤泡性淋巴瘤组织学转化病例,其表现为原淋巴细胞样形态,具有不寻常的免疫表型,特征为CD5和CD10共表达。通过流式细胞术和免疫组织化学检测,转化后的原淋巴细胞样淋巴瘤的CD5和CD10抗原均呈阳性。该病例还表达bcl-2和bcl-6蛋白,并显示t(14;18),这与源自先前存在的滤泡性淋巴瘤一致。对来自滤泡性淋巴瘤和原淋巴细胞样淋巴瘤的免疫球蛋白κ轻链基因进行聚合酶链反应分析,结果显示相同的重排条带,提示这两种肿瘤具有克隆同一性。CD5和CD10共表达的机制尚不清楚。由于先前的低级别滤泡性淋巴瘤仅CD10呈阳性,不表达CD5,因此在该特定病例中,CD5表达似乎是组织学转化过程中出现的一种获得性现象。与滤泡性淋巴瘤的其他组织学转化形式相似,原淋巴细胞样转化似乎伴随着疾病的临床进展。